ArticleGland surgery2025
Fluorescent intraoperative tissue angiography during breast reduction: a single institution, single surgeon study evaluating decrease in complication rates with acquired proficiency.
Article in Gland surgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Fluorescent intraoperative tissue angiography (FITA) provides real-time perfusion analysis that predicts which tissues will progress to postoperative ischemic necrosis. This technology helps guide the surgeon to resect the at-risk tissues preemptively. The purpose of our study was to evaluate whether clinical outcomes are affected by the level of experience with FITA for superomedial-pedicle breast reduction (SBR). Methods: A retrospective, sequential series of 50 patients who underwent single-surgeon bilateral reduction mammaplasty using FITA (SPY Elite, Stryker, Kalamazoo, MI, USA) between April 2015 and September 2020 were included in the study. Two groups from the series were formed: the first three years with 25 patients (Group A) and the last three years with 25 patients (Group B). Operative data included FITA perfusion indices (medial breast, lateral breast, and nipple-areolar complex) and resection weight. Post-operative complications such as return to operating room (RTOR), and skin or nipple loss were reported. Results: Two statistically significant changes were observed: superomedial perfusion indices increased (right breast P<0.001, left breast P=0.02) and resection weights decreased (right breast P=0.044, left breast P=0.007). While the number of observed complications (nipple sensation, minor skin loss, RTOR), decreased in Group B compared to Group A, the difference was not statistically significant (P=0.62). The rate of minor skin or nipple loss was reduced by 57% in Group B versus Group A). Conclusions: FITA may help guide the preservation of perforators in the breast reduction pedicle. Though doing so did not reveal any statistical reduction in the number of complications in our study. These findings require further investigation for definitive conclusions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.